Neuroblastoma Protocol 2012: Therapy for Children With Advanced Stage High-Risk Neuroblastoma
Phase of Trial: Phase II
Latest Information Update: 10 Jun 2017
At a glance
- Drugs Dinutuximab (Primary) ; Antineoplastics; Natural killer cell therapy
- Indications Neuroblastoma
- Focus Therapeutic Use
- 05 Jun 2017 Results assessing early response rates (n=42), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 06 Sep 2016 Planned number of patients changed from 150 to 210.
- 04 Aug 2016 Planned End Date changed from 1 Jun 2019 to 1 Jul 2021.